Скачать или смотреть NO WAY: One Scan Predicts Heart and Liver Trouble 😱

7 real studies: chikungunya outbreak vaccination, treating migraine prodrome before pain, one scan for heart + liver risk, custom gene editing for a baby, Crispr-tuned T cells in colorectal cancer, liver regeneration “switches,” and vascularized mini islets for diabetes. We break down what was actually tested, what the results truly show, and why it matters for public health, prevention, and next-gen therapies.

Which study surprised you most—and which one raises the biggest questions? Drop your take in the comments, hit like, and subscribe to Brain Buffet for more real science with a punch.

#Chikungunya #MosquitoVirus #OutbreakResponse #VaccineCampaign #Seroprevalence #EpidemicModeling #Migraine #CGRP #Ubrogepant #Prodrome #HeartHealth #LiverHealth #MetabolicHealth #MRIScreening #GeneEditing #BaseEditing #RareDisease #CancerImmunotherapy #LiverRegeneration #DiabetesResearch

chikungunya outbreak vaccine,seroprevalence study,epidemic reconstruction,mosquito-borne virus,public health trigger thresholds,vaccine stockpile planning,ubrogepant prodrome trial,CGRP receptor antagonist,migraine early treatment,prodromal symptoms relief,heart and liver combined scan,MASLD risk prediction,cardiovascular events prediction,quantitative liver MRI marker,personalized gene editing baby,base editor in vivo,lipid nanoparticle delivery,CRISPR edited TIL therapy,CISH intracellular checkpoint,liver regeneration enhancer map